Back
Esperion Therapeutics Quote, Financials, Valuation and Earnings
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
28
ESPR
Esperion Therapeutics
Last Price:
2.14
Seasonality Move:
-9.97%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Esperion Therapeutics Price Quote
$2.14
+0.08 (+3.63%)
(Updated: May 3, 2024 at 9:55 AM ET)
Esperion Therapeutics Key Stats
Sell
28
Esperion Therapeutics (ESPR)
is a Sell
Day range:
$2.03 - $2.12
52-week range:
$0.70 - $3.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.83
P/B ratio:
0%
Volume:
2.8M
Avg. volume:
8M
1-year change:
56.44%
Market cap:
$382.1M
Revenue:
$116.3M
EPS:
$-2.12
How Much Does Esperion Therapeutics Make?
-
How Much Are Esperion Therapeutics's Sales Annually?
ESPR Revenues are $116.3M -
How Much Profit Does Esperion Therapeutics's Make A Year?
ESPR net income is -$209.2M
Is Esperion Therapeutics Growing As A Company?
-
What Is Esperion Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.71% -
What Is Esperion Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Esperion Therapeutics Stock Price Performance
-
Did Esperion Therapeutics Stock Go Up Last Month?
Esperion Therapeutics share price went down by -28.3% last month -
Did ESPR's Share Price Rise Over The Last Year?
ESPR share price rose by 56.44% over the past 1 year
What Is Esperion Therapeutics 52-Week High & Low?
-
What Is Esperion Therapeutics’s 52-Week High Share Price?
Esperion Therapeutics has traded as high as $3.40 over the past 52 weeks -
What Is Esperion Therapeutics’s 52-Week Low Share Price?
Esperion Therapeutics has traded as low as $0.70 over the past 52 weeks
Esperion Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Esperion Therapeutics?
-
How Much Debt Does Esperion Therapeutics Have?
Total long term debt quarterly is $261.6M -
How Much Cash Does Esperion Therapeutics Have?
Cash and short term investments quarterly total is $82.2M -
What Is Esperion Therapeutics’s Book Value Per Share?
Book value per share is -3.85
Is Esperion Therapeutics Cash Flow Positive?
-
What Is ESPR Cash Flow From Operations?
Cash flow from operations (TTM) is -$135.5M -
What Is Esperion Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $50.5M -
What Is Esperion Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $42.5M
Esperion Therapeutics Return On Invested Capital
Data Unavailable
Esperion Therapeutics Earnings Date & Stock Price
-
What Is Esperion Therapeutics's Stock Price Today?
A single share of ESPR can be purchased today for 2.07 -
What Is Esperion Therapeutics’s Stock Symbol?
Esperion Therapeutics trades on the nasdaq under the ticker symbol: ESPR -
When Is Esperion Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Esperion Therapeutics is scheduled on May 7, 2024 -
When Is ESPR's next ex-dividend date?
Esperion Therapeutics's next ex-dividend date is May 3, 2024 -
How To Buy Esperion Therapeutics Stock?
You can buy Esperion Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Esperion Therapeutics Competitors
-
Who Are Esperion Therapeutics's Competitors?
Below is a list of companies who compete with Esperion Therapeutics or are related in some way:
Esperion Therapeutics Dividend Yield
Data Unavailable
Esperion Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -4.61% |
| Revenue: | 71.38% | 12.36% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 7.41 |
| Upside from Last Price: | 259.05% |